Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Psychedelic Perceptions in 2021: Popular Culture & Controversy

Psychedelic Perceptions in 2021: Popular Culture & Controversy

  • Post published:January 26, 2022
  • Post category:Analysis
Read more about the article Psychedelic Company Highlights in 2021

Psychedelic Company Highlights in 2021

  • Post published:January 20, 2022
  • Post category:Analysis
Read more about the article Psychedelic Research and Clinical Trials in 2021

Psychedelic Research and Clinical Trials in 2021

  • Post published:January 10, 2022
  • Post category:Analysis
Read more about the article Psychedelic Drug Policy Reform in 2021

Psychedelic Drug Policy Reform in 2021

  • Post published:January 5, 2022
  • Post category:Analysis
Read more about the article Psychedelics 2021: A Year in Review

Psychedelics 2021: A Year in Review

  • Post published:January 5, 2022
  • Post category:Analysis
Read more about the article Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be?

Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be?

  • Post published:November 5, 2021
  • Post category:Analysis/News
Read more about the article Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and the Law

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and the Law

  • Post published:June 30, 2021
  • Post category:Analysis/News
Read more about the article MagicMed to Be Acquired by Nasdaq-Listed Company

MagicMed to Be Acquired by Nasdaq-Listed Company

  • Post published:May 24, 2021
  • Post category:Analysis/News
Read more about the article Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies

Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies

  • Post published:March 23, 2021
  • Post category:Analysis/Editorial
Read more about the article Experiential Psilocybin-assisted Therapy Training Program, Approved by Health Canada, Gets Underway

Experiential Psilocybin-assisted Therapy Training Program, Approved by Health Canada, Gets Underway

  • Post published:March 2, 2021
  • Post category:Analysis/News

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More